Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

Journal of Clinical Microbiology
M A PfallerGlobal Antifungal Surveillance Group

Abstract

We examined data from the ARTEMIS DISK Antifungal Surveillance Program to describe geographic and temporal trends in the isolation of Candida parapsilosis from clinical specimens and the in vitro susceptibilities of 9,371 isolates to fluconazole and voriconazole. We also report the in vitro susceptibility of bloodstream infection (BSI) isolates of C. parapsilosis to the echinocandins, anidulafungin, caspofungin, and micafungin. C. parapsilosis represented 6.6% of the 141,383 isolates of Candida collected from 2001 to 2005 and was most common among isolates from North America (14.3%) and Latin America (9.9%). High levels of susceptibility to both fluconazole (90.8 to 95.8%) and voriconazole (95.3 to 98.1%) were observed in all geographic regions with the exception of the Africa and Middle East region (79.3 and 85.8% susceptible to fluconazole and voriconazole, respectively). C. parapsilosis was most often isolated from blood and skin and/or soft tissue specimens and from patients hospitalized in the medical, surgical, intensive care unit (ICU) and dermatology services. Notably, isolates from the surgical ICU were the least susceptible to fluconazole (86.3%). There was no evidence of increasing azole resistance over time among C....Continue Reading

References

Mar 11, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J J Weems
May 1, 1988·Journal of Clinical Microbiology·K J McGinleyJ J Leyden
Sep 1, 1994·Journal of Clinical Microbiology·L J StrausbaughR Tjoelker
Feb 1, 1994·Journal of Clinical Microbiology·M L BranchiniH D Isenberg
Sep 1, 1995·The Pediatric Infectious Disease Journal·H SaxenH Peltola
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M A Pfaller
Jun 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Abi-SaidS Vartivarian
Dec 24, 1997·Diagnostic Microbiology and Infectious Disease·D J DiekemaM A Pfaller
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I LevyS K Sood
Aug 25, 1999·Diagnostic Microbiology and Infectious Disease·A L ColomboS B Wey
Jun 29, 2002·Journal of Clinical Microbiology·Antonella LupettiSonia Senesi
Dec 20, 2002·The New England Journal of Medicine·Jorge Mora-DuarteUNKNOWN Caspofungin Invasive Candidiasis Study Group
Aug 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN NIAID Mycoses Study Group
Sep 25, 2003·Antimicrobial Agents and Chemotherapy·Luis Ostrosky-ZeichnerJeannette Lee
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Jan 30, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M A PfallerUNKNOWN International Fungal Surveillance Participant Group
Jun 23, 2004·Emerging Infectious Diseases·Duncan M KuhnMahmoud A Ghannoum
Dec 29, 2004·The Journal of Hospital Infection·L A BonassoliT I E Svidzinski
Apr 9, 2005·Journal of Clinical Microbiology·Benito AlmiranteUNKNOWN Barcelona Candidemia Project Study Group
Jul 16, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lucia Garcia San MiguelSantiago Moreno
Jul 16, 2005·Memórias do Instituto Oswaldo Cruz·R S N BrilhanteJ J C Sidrim
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Theoklis E ZaoutisChris Feudtner
Oct 19, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott K Fridkin
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad J SpellbergJohn E Edwards
Mar 7, 2006·Journal of Clinical Microbiology·M A PfallerD J Diekema
Mar 21, 2006·Revista Do Instituto De Medicina Tropical De São Paulo·Delia Jessica Astete MedranoJosé Júlio Costa Sidrim
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Francesco BarchiesiGiorgio Scalise
Sep 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elias K SpanakisEleftherios Mylonakis
Dec 21, 2006·Infection·C CheungM Feldmesser
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema

❮ Previous
Next ❯

Citations

Aug 8, 2009·Current Genetics·Jozef NosekLubomir Tomaska
May 26, 2009·Revista iberoamericana de micología·Guillermo QuindósJavier Pemán
May 29, 2012·The Journal of Antimicrobial Chemotherapy·Elisabetta SpreghiniFrancesco Barchiesi
Nov 10, 2010·Antimicrobial Agents and Chemotherapy·Fernando C BizerraArnaldo L Colombo
Apr 27, 2011·Antimicrobial Agents and Chemotherapy·A P SilvaA G Rodrigues
Oct 24, 2012·Antimicrobial Agents and Chemotherapy·Louise A WalkerCarol A Munro
Feb 19, 2009·Antimicrobial Agents and Chemotherapy·Manuel Cuenca-EstrellaJuan L Rodriguez-Tudela
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·D AndesA Lepak
Sep 10, 2008·Drugs·Maria J G T RüpingOliver A Cornely
Dec 24, 2010·Drugs·Sharon C-A ChenTania C Sorrell
Dec 17, 2008·Future Microbiology·Pola de la TorreAnnette C Reboli
May 29, 2010·Medical Mycology·Carlotta Francesca OrsiElisabetta Blasi
Mar 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mario Fernández-RuizUNKNOWN REIPI
Mar 23, 2011·Expert Review of Anti-infective Therapy·Anıl Tapısız
Aug 20, 2008·Expert Opinion on Pharmacotherapy·Jomy M JosephAnnette C Reboli
May 12, 2009·Expert Opinion on Investigational Drugs·Maria J G T RuepingOliver A Cornely
Sep 27, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Liang-Yu ChenFu-Der Wang
Sep 11, 2013·Journal of Critical Care·George DimopoulosJean-Louis Vincent
May 18, 2013·Revista iberoamericana de micología·María Teresa Blanco-BlancoMaría Teresa Blanco
Apr 1, 2011·Enfermedades infecciosas y microbiología clínica·Miguel Montejo, Guillermo Quindós
May 11, 2010·Revista iberoamericana de micología·Alejandra Zuluaga RodríguezAngel González Marín
Apr 30, 2009·Journal of Structural Biology·Jirí DostálPavlína Rezácová
Nov 6, 2009·Clinical Pharmacology and Therapeutics·D K BenjaminT J Walsh
May 12, 2012·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Anupama RaghuramChristine E Koval
Jun 15, 2011·Mycoses·Jomy George, Annette C Reboli
Jan 22, 2010·Critical Reviews in Microbiology·Michael A Pfaller, Daniel J Diekema
Oct 14, 2009·Critical Reviews in Microbiology·Eveline C van AsbeckDavid A Stevens
Apr 7, 2015·Expert Opinion on Pharmacotherapy·Lorena Botero-CalderonMichael Cohen-Wolkowiez
Jan 12, 2011·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Adriana Lopes MottaFlávia Rossi
Apr 30, 2016·The Journal of Antimicrobial Chemotherapy·Nelesh P GovenderUNKNOWN TRAC-South Africa group
Jul 8, 2016·Transplant Infectious Disease : an Official Journal of the Transplantation Society·I GassiepE G Playford

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.